Madrigal Pharmaceuticals, Inc.

NasdaqGS:MDGL Stock Report

Market Cap: US$11.9b

Madrigal Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:MDGL Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 May 26SellUS$435,420David SoergelIndividual844US$515.90
06 Mar 26SellUS$279,033Mardi DierIndividual646US$431.94
06 Mar 26SellUS$155,498Shannon KelleyIndividual360US$431.94
06 Mar 26SellUS$718,316William SiboldIndividual1,663US$431.94
06 Mar 26SellUS$212,083Rebecca TaubIndividual491US$431.94
06 Mar 26SellUS$180,983Carole HuntsmanIndividual419US$431.94
02 Mar 26SellUS$505,389Mardi DierIndividual1,183US$427.21
26 Jan 26SellUS$167,423Carole HuntsmanIndividual340US$492.42
26 Jan 26SellUS$318,596Rebecca TaubIndividual647US$492.42
26 Jan 26SellUS$776,546William SiboldIndividual1,577US$492.42
20 Jan 26SellUS$1,098,343Rebecca TaubIndividual2,238US$490.77
20 Jan 26SellUS$129,073Shannon KelleyIndividual263US$490.77
21 Nov 25SellUS$1,082,986Carole HuntsmanIndividual1,958US$564.57
09 Sep 25SellUS$3,243,741William SiboldIndividual7,279US$445.63
20 Aug 25BuyUS$56,697,740Baker Bros. Advisors LPCompany151,707US$392.24
20 Aug 25BuyUS$5,223,284667, L.P.Company13,976US$392.24
18 Aug 25SellUS$164,266Shannon KelleyIndividual458US$358.66

Insider Trading Volume

Insider Buying: MDGL insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of MDGL?
Owner TypeNumber of SharesOwnership Percentage
Private Companies854,5283.18%
Individual Insiders1,957,2997.28%
Hedge Funds7,345,75727.3%
Institutions16,733,06362.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 86.76% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.29%
Baker Bros. Advisors LP
2,141,701US$1.1b0%5.63%
8.76%
Janus Henderson Group plc
2,018,647US$1.0b27.4%0.35%
8.65%
RTW Investments, LP
1,993,687US$1.0b0%10.1%
7.89%
Avoro Capital Advisors LLC
1,818,181US$940.5m0.59%10.65%
6.77%
BlackRock, Inc.
1,559,942US$806.9m-5.15%0.01%
6.04%
Paulson & Co. Inc.
1,392,188US$720.1m-18.5%14.52%
4.14%
Paul Friedman
953,995US$493.5m478%no data
3.65%
Vanguard Portfolio Management, LLC
841,145US$435.1m0%0.02%
3.59%
Vanguard Capital Management, LLC
827,144US$427.8m0%0.01%
3.01%
Wellington Management Group LLP
694,958US$359.5m50.6%0.05%
2.84%
SQN, LLC
655,540US$339.1m0%no data
2.64%
State Street Global Advisors, Inc.
609,525US$315.3m4.55%0.01%
2.22%
FMR LLC
511,622US$264.6m16.6%0.01%
1.98%
Geode Capital Management, LLC
455,870US$235.8m0.91%0.01%
1.97%
Citadel Advisors LLC
453,843US$234.8m1,160%0.16%
1.91%
Rebecca Taub
440,429US$227.8m0.82%no data
1.6%
Frederick Craves
368,004US$190.4m0%no data
1.54%
William Blair Investment Management, LLC
354,222US$183.2m-3.72%0.23%
1.42%
T. Rowe Price Group, Inc.
328,110US$169.7m4.61%0.01%
1.35%
Invesco Ltd.
311,732US$161.2m-4.71%0.04%
1.25%
Polar Capital Holdings Plc
289,310US$149.6m7.09%0.33%
1.15%
Armistice Capital LLC
264,583US$136.9m-0.42%3.76%
1.08%
Hood River Capital Management LLC
249,511US$129.1m0.79%1.03%
1.05%
Lord, Abbett & Co. LLC
242,726US$125.6m-0.85%0.35%
0.98%
Point72 Asset Management, L.P.
225,510US$116.6m78.4%0.19%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/26 11:58
End of Day Share Price 2026/05/22 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Madrigal Pharmaceuticals, Inc. is covered by 28 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Eliana MerleBarclays
Matthew LuchiniBMO Capital Markets Equity Research
Jason ZemanskyBofA Global Research